Quality of life assessment is an integral part of a comprehensive treatment in modern medical practice. Analysis of quality of life of patients with comorbidities is an interesting and poorly understood issue.
The objective of the research was to evaluate the quality of life of patients with postinfarction cardiosclerosis depending on the presence and progression of non-alcoholic fatty liver disease (NAFLD).
Material and methods. The research included 300 patients with stable coronary artery disease (CAD). They included 160 patients without NAFLD (Group I) and 140 patients with NAFLD (Group II). 89 patients of Group II suffered from non-alcoholic liver disease (NALD) and 51 patients from non-alcoholic steatohepatitis (NASH). The control group consisted of 20 apparently healthy individuals. SF-36 and MacNew questionnaires were used to assess the quality of life.
Results. The overall estimate according to SF-36 questionnaire detected a significant decrease in the patient’s quality of life due to their low physical activity, mental ill-being, limitation of daily activities, significant effect of pain and low assessment of their health. Decrease in the quality of life was clearly dependent on NAFLD stage and was the lowest in case of NASH. The overall estimate of quality of life according to MacNew questionnaire was 1.5 times lower in patients of Group I compared to the control group, decreased almost by 1.4 times in patients with NALD compared to Group I and was 1.5 times lower in case of NASH compared to the patients with NALD (p<0.05).
Conclusions. Patients with stable CAD combined with NAFLD were characterized by decrease in quality of life due to its physical, psycho-emotional and social components. Quality of life of patients with postinfarction cardiosclerosis depended on NAFLD progression and was the lowest in case of NASH.
Ivachevska V, Chopej I. [Assessment of quality of life in patients with combination of nonalcoholic fatty liver disease and stable forms of coronary heart disease]. Hastroenterolohiia. 2014;3(53):35–37
Radchenko GD, Martsovenko IM, Sirenko YuM. Oysinka yakosti zhyttia patsientiv z arterialnoiu hipertensiieiu na ambulatorno-poliklinichnomu etapi (Resultaty 6-misiachnoho sposterezhennia). Arter Hyper [Internet]. 2012;2(22)
Khobzei MK, Kharchenko NV, Lishchyshyna OM. Unifikovanyi klinichnyi protokol "Nealkoholnyi steatohepatiyt". MOH of Ukraine Order #826 of 06 Nov 2014 [Internet].
Kravchenko VV, Sokolov MYu, Talayieva TV, et al. Unifikovanyi klinichnyi protokol "Stabilna ishemichna khvoroba sertsia". MOH of Ukraine Order #152 of Feb 03 2016 [Internet].
Yagenskyi AV, Höfer S, Sichkaruk IM. [Quality of life assessment in patients with ischemic heart disease: validation of Ukrainian-language version of MacNew Heart Disease Health-related Quality of Life]. Ukraiinskyi kardiolohichnyi zhurnal. 2013;3:22–28
Yepanchintseva OA, Nadorak OP, Borkhalenko YuA. [Quality of life in patients with stable coronary artery disease: a place of ranolazine]. Ukraiinskyi kardiolohichnyi zhurnal. 2015;3:79–83
Committee for Medicinal Products for Human Use. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. European Medicines Agency [Internet]. 2005.
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol [Internet]. 2016 Jun;64(6):1388–1402. DOI: http://doi.org/10.1016/j.jhep.2015.11.004 [PMid: 27062661]
Oldridge N, Höfer S, McGee H, et al. The HeartQoL: Part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol. 2014;21(1):90–97. DOI: http://doi.org/10.1177/2047487312450544 [PMid: 22822179]
Oldridge N, Hofer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: Part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol. 2014 Jan 1;21(1):98–106. DOI: http://doi.org/10.1177/2047487312450545
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.